Company: EUDAW
Filing Date: 2025-12-04
Form Type: 424B5
Source: 0001493152-25-026224
Chunk: 14

Company: EUDA Health Holdings Ltd
Filing Date: 2025-12-04
Form: 424B5
Chunk 14
---
 $7.50. Although we have the right to require the Investor to pay us the Exercise Price in cash for its exercise of the Warrant during the Cash Exercise Period if among other things, (i) the closing price of our ordinary shares on Nasdaq exceeds $7.50 per share for five (5) consecutive days within ninety (90) days from the day of issuance (the “Measurement Period”) of the Warrant, and (ii) the cumulative trading dollar volume (the “Cumulative Volume”) over the Measurement Period is at least $1,500,000, there is no assurance that these and other conditions required for a Forced Exercise will be met. Absent a Forced Exercise, we may not receive any cash proceeds from the Investor in connection with the Warrant exercise unless the Investor chooses to exercise the Warrant during the Cash Exercise Period.

If we fail to pay the Investor 125% of the original purchase price of the Warrant during the Repurchase Period, we will be required to issue up to 200,000 Warrant Shares to the Investor as a result of a cashless exercise of the Warrant.

For a period of two (2) weeks following the end of the Cash Exercise Period (the “Repurchase Period”), we will have the right to repurchase any remaining portion of the then outstanding Warrant in cash for $0.0625 per Warrant Share under the Warrant. If we fail to pay 125% of the original purchase price of the Warrant, the Warrant will be automatically deemed exercised for up to 200,000 ordinary shares and the Company will not receive any proceeds as a result of this cashless exercise. Even in the case of Forced Exercise, the number of Warrant Shares that the Company may require the Investor to purchase pursuant to a Forced Exercise will be limited to only ten percent (10%) of the Cumulative Volume. In the event of a breach of any term or covenant of the Purchase Agreement, the Company will be required to issue up to 400,000 Warrant Shares to the Investor. There is no guarantee that the Company will receive any additional consideration from the Investor in connection with the issuance of up to 400,000 Warrant Shares pursuant to the terms of the Warrant.

Raising additional capital will be difficult and may cause dilution to our shareholders and restrict our operations.

We expect to finance our cash needs to fund the operation of our newly acquired businesses and for our working capital. Although we have been able to obtain funding from outside sources